Overview
Dr. Sheema Almozayan is a postdoctoral fellow in Cell Therapy and Immunobiology at KFSHRC and is currently undertaking her fellowship at the Koch Institute for Integrative Cancer Research, MIT, in Prof. Jianzhu Chen’s laboratory, supported by the KACST–MIT Ibn Khaldun Postdoctoral Fellowship. She holds a PhD in Pre-clinical Oncology from the University of Nottingham and an MSc in Molecular Medicine from Trinity College Dublin.
Her research focuses on engineering CAR T-cell therapies, including TCR-like CAR constructs targeting intracellular tumor antigens, as well as antibody engineering and the development of CAR NK-cell platforms. She is also engaged in translational research and industry collaborations to advance innovative immunotherapeutic strategies, including the development of novel CAR NK-cell approaches for autoimmune diseases with potential clinical translation. In addition, she has extensive experience in patient-derived organoid (PDO) models, 3D tissue systems, genome editing, and preclinical platforms for evaluating cellular immunotherapies.